Journal of the American Heart Association

DECEMBER 1, 2023

Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. Alternative pharmacologic and nonpharmacologic strategies warrant investigation. BackgroundAn increased risk of recurrent stroke is noted in patients with atrial fibrillation despite direct oral anticoagulant (DOAC) use. 0.41] for rivaroxaban).ConclusionsIn

Atrial Fibrillation 75

Atrial Fibrillation Hemorrhage Pharmacology Strokes 75

Journal of Cardiovascular Pharmacology

OCTOBER 9, 2023

Sodium-glucose cotransporter 2 (SGLT2) inhibitors represent one of the most important pharmacological innovations in the field of Cardiology of the last decades, having shown significant outcome improvement in all the heart failure (HF) spectrum. Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Heart Failure 40

Heart Failure Pharmacology Innovation Outcomes 40

DAIC

DECEMBER 12, 2023

milla1cf Tue, 12/12/2023 - 08:00 December 12, 2023 — Think of them as the Energizer Bunnies of the heart, tiny natural batteries that keep this vital organ beating 100,000 times a day as it pumps 2,000 gallons of blood throughout the human body.

Heart attacks 105

Heart attacks Heart Attack Heart Disease Pharmacology 105

Open Heart

JUNE 18, 2024

We identified all randomised trials which evaluated the effect of any pharmacological, device-based or supportive intervention on patients with a history of syncope. A systematic search was conducted on Medline, Embase, PubMed databases and Cochrane Central Register for Controlled Trials from 1950 to 25 April 2023.

Pharmacology 52

Pharmacology 52

Frontiers in Cardiovascular Medicine

OCTOBER 15, 2024

An updated search was conducted in October 2023 to identify additional studies.Results2,381 studies were screened for title/abstract relevancy. Future EBI should target this underserved/high-burden group to improve disparity gaps within BP reduction via non-pharmacological means.

Blood Pressure 52

Blood Pressure Pharmacology Article Outcomes 52

DAIC

DECEMBER 22, 2023

Tricuspid regurgitation (TR) is a common and serious disease for which open heart surgery and symptomatic pharmacologic treatment are the current standard treatment options. Owing to high mortality risk, access to open heart surgery is severely restricted and is not considered an option for most patients with TR.

Tricuspid 59

Tricuspid Pacemaker Heart Valves Open-Heart Surgery 59

Stroke Journal

JANUARY 30, 2025

This study aimed to identify proteomic expression patterns in large core infarct patients undergoing MT to inform potential pharmacological intervention targets.Methods:The Blood And Clot Thrombectomy Registry And Collaboration (BACTRAC) tissue registry was reviewed for anterior circulation MT patients treated between June 2017-December 2023.

Stroke 40

Stroke Strokes Pharmacology Myocardial Infarction 40

Journal of Cardiovascular Pharmacology

JULY 31, 2023

The aim of this review is to summarize the literature, guidelines, and future directions on the pharmacological treatment of ICI myocarditis. The aim of this review is to summarize the literature, guidelines, and future directions on the pharmacological treatment of ICI myocarditis. Copyright © 2023 Wolters Kluwer Health, Inc.

Cancer 40

Cancer Pharmacology Outcomes Article 40

Journal of Cardiovascular Pharmacology

SEPTEMBER 19, 2023

Betrixaban offers distinct pharmacological characteristics, including a long half-life, low renal excretion, and unique hepatic metabolism, making it an attractive option for various theoretical uses. Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Article 40

Article Pharmacology Hospital 40

Open Heart

APRIL 2, 2024

Virtual reality (VR) is a promising non-pharmacological intervention to reduce anxiety in patients undergoing ICA. Ethics and dissemination The protocol of this study has been approved by the Research Ethics Committee of the Radboud University Medical Centre, the Netherlands (CMO Arnhem-Nijmegen, 2023–16586).

Physiology 40

Physiology Pharmacology Research Outcomes 40

Hypertension Journal

OCTOBER 10, 2023

Hypertension, Volume 80, Issue 12 , Page 2515-2522, December 1, 2023. Cardiovascular disease is often a disease of aging.

Cardiovascular Disease 40

Cardiovascular Disease Risk Factors Pharmacology Research 40

Journal of Cardiovascular Pharmacology

NOVEMBER 22, 2023

Copyright © 2023 Wolters Kluwer Health, Inc. Patient administration of aspirin or (and) clopidogrel inhibited platelet adhesion and aggregation on the glass surface under flow conditions. Patient administration of aspirin or (and) clopidogrel inhibited platelet adhesion and aggregation on the glass surface under flow conditions.

Physiology 40

Physiology Thrombosis Pharmacology Technology 40

Circulation

NOVEMBER 11, 2024

Despite comprehensive anticoagulation protocols, discrepancies in pharmacologic responses due to patient-specific factors such as adherence to anticoagulation, renal function, and genetics suggest that imaging studies may still be critical for patient safety.

Echocardiogram 40

Echocardiogram Atrial Fibrillation Stroke Strokes 40

The British Journal of Cardiology

NOVEMBER 29, 2023

Overall, comprehensive assessment and pharmacological modification of risk factors are central to stroke prevention. In patients with diabetes, good glycaemic control can reduce stroke risk. Inflammation is another emerging target for stroke prevention.

Strokes 40

Strokes Stroke Risk Factors Blood Pressure 40

Dr. Paddy Barrett

APRIL 5, 2024

2023 Nov 11. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. N Engl J Med. 10 Blood Pressure Lowering Treatment Trialists' Collaboration.

Heart Disease 118

Heart Disease Coronary Artery Disease Heart attacks Heart Attack 118

Cardiometabolic Health Congress

JANUARY 3, 2024

In January of 2023, the FDA also approved semaglutide for the treatment of obesity in adolescents aged 12 to 17 years. The drug works by mimicking the glucagon-like peptide-1 (GLP-1) hormone which targets areas of the brain that regulate appetite and food intake.

Obesity 97

Obesity Diabetes Blood Pressure BMI 97

Journal of Cardiovascular Pharmacology

DECEMBER 19, 2023

Copyright © 2023 Wolters Kluwer Health, Inc. In conclusion, a three-day 40 mg atorvastatin administration is sufficient to reduce FVII and FXI activity in our pilot study, which is associated with favorable fibrin clot properties modification. All rights reserved.

Article 98

Article 98

Cardiology Update

JANUARY 7, 2024

Fellows 2024 offers hands-on training covering revascularization, angioplasty, stents, pharmacologic therapy, and intravascular imaging/physiology. Noncoronary topics like structural heart disease and vascular medicine are also addressed. Ample networking opportunities with faculty are provided.

Interventional Cardiology 64

Interventional Cardiology Innovation Heart Disease Physiology 64

Heart 2023 Conference

FEBRUARY 25, 2023

There are numerous programs available for cases both virtual or in-person options, as well as different nicotine relief and pharmacologic options to help you quit. Being open with your physician about your tobacco use is important so we can help understand what walls may live that decelerate your progress and help you quit.

Blood Pressure 52

Blood Pressure Cholesterol Heart Disease Exercise 52

Dr. Smith's ECG Blog

OCTOBER 23, 2023

PMID: 11723026. == MY Comment , by K EN G RAUER, MD ( 10/23 /2023 ): == The various forms of electrical alternans are frequently misunderstood, if not completely unnoticed. This may result from fluctuations in heart rate or in nervous system activity or from pharmacologic treatment. Circulation. 2001 Nov 27;104(22):2722-7.

Tachycardia 130

Tachycardia Cardiac Arrest ICU Blog 130

DAIC

JANUARY 23, 2024

As of June 2023, the U.S. Accessed November 8, 2023. Accessed January 18, 2023. AGEPHA Pharma FZ LLC; 2023. Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review. The repurposed drug is safe, cost-effective and efficacious. FDA approved LODOCO (colchicine, 0.5 J Am Coll Cardiol.

Cardiovascular Disease 111

Cardiovascular Disease Heart attacks Heart Attack Coronary Artery Disease 111

DAIC

FEBRUARY 29, 2024

24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. This observation needs further investigation to determine if certain local and systemic factors might contribute to TNK’s adverse outcome profile in the EVT population despite its pharmacological superiority compared to ALT.

Thrombolysis 40

Thrombolysis Pharmacology Stroke Strokes 40

Dr. Smith's ECG Blog

DECEMBER 13, 2024

Hence, the IV Amiodarone was once one of the 2nd-line choices for acute pharmacologic cardioversion in such patients without hemodynamic instability. 2023, January 31). However, a relatively recent paper found that 18 of 30 stable patients with AF and WPW converted to sinus and no ventricular acceleration or VF developed. (

AFIB 103

AFIB Atrial Fibrillation Tachycardia Blog 103

Journal of Cardiovascular Pharmacology

NOVEMBER 21, 2023

We performed a systematic search of Embase, PubMed, and web of science until February 2023. We performed a systematic search of Embase, PubMed, and web of science until February 2023. Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Aortic valve 40

Aortic valve Aortic TAVR Myocardial Infarction 40

Journal of Cardiovascular Pharmacology

DECEMBER 20, 2023

Copyright © 2023 Wolters Kluwer Health, Inc. However, the patients who were prescribed midodrine achieved better initiation and uptitration of GDMT at 6 months compared to those who were not prescribed midodrine. All rights reserved.

Heart Failure 52

Heart Failure Hospital Outcomes Article 52

Journal of Cardiovascular Pharmacology

MARCH 24, 2024

We systematically searched the PubMed, Embase, and Cochrane Library electronic databases, with a cutoff date of November 23, 2023, for studies reporting outcomes in adult patients with advanced HF treated with intermittent, repeated, or continuous levosimendan, milrinone, or dobutamine.

Heart Failure 40

Heart Failure Outcomes Article 40

Journal of Cardiovascular Pharmacology

OCTOBER 8, 2023

Copyright © 2023 Wolters Kluwer Health, Inc. There is also growing evidence for using anti-inflammatory and immunosuppressive agents for treating recurrent pericarditis, which can overlap with the treatment of rheumatic diseases. All rights reserved.

Pericarditis 40

Pericarditis Article 40

Journal of Cardiovascular Pharmacology

JANUARY 8, 2024

From inception until August 2023, we systematically searched five public literature databases to conduct the umbrella review. From inception until August 2023, we systematically searched five public literature databases to conduct the umbrella review. However, its efficacy has not been assessed extensively.

Cardiovascular Disease 40

Cardiovascular Disease Coronary Artery Disease Angina Heart Failure 40

Journal of Cardiovascular Pharmacology

OCTOBER 9, 2024

This study compares outcomes in AF patients with GIB on AC alone to those on combination AP and AC therapy, as part of a larger prospective study from 2013 to 2023. This study compares outcomes in AF patients with GIB on AC alone to those on combination AP and AC therapy, as part of a larger prospective study from 2013 to 2023.

Atrial Fibrillation 40

Atrial Fibrillation Myocardial Infarction Kidney Disease Stents 40

Ken Grauer, MD

MARCH 12, 2023

A DDENDUM ( 3/13/2023 ) : I've presented this material before — but it bears repeating for reference. T oday's C ASE C ontinues : Follow-up on today's patient is unfortunately limited ( ie, No EP study was done ). ECG Blog #197 — Reviews the common forms of Idiopathic VT ( including Fascicular VT).

Blog 78

Blog Atrial Flutter Arrhythmia AFIB 78

Journal of Cardiovascular Pharmacology

MAY 7, 2024

A systematic literature search was conducted in the MEDLINE and Embase databases for articles published between the earliest date and April 2023 reporting cardiac conduction abnormalities in patients with systemic autoimmune rheumatic diseases taking HCQ or CQ.

Sudden Cardiac Death 40

Sudden Cardiac Death Arrhythmia Article Outcomes 40

Journal of Cardiovascular Pharmacology

NOVEMBER 21, 2023

Copyright © 2023 Wolters Kluwer Health, Inc. These results show that both the use of renin-angiotensin inhibitors (RASIs) and Sacubitril/Valsartan (SV) can prevent the recurrence of after atrial fibrillation ablation, among which the use of Sacubitril/Valsartan (SV) is more effective. All rights reserved.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Research Article 40

Journal of Cardiovascular Pharmacology

APRIL 9, 2024

We conducted a comprehensive search of PubMed, Embase, and Cochrane Library encompassing data from inception until November 30, 2023. We conducted a comprehensive search of PubMed, Embase, and Cochrane Library encompassing data from inception until November 30, 2023.

Myocardial Infarction 40

Myocardial Infarction Diabetes Heart Failure Hospital 40

Journal of Cardiovascular Pharmacology

SEPTEMBER 25, 2023

Copyright © 2023 Wolters Kluwer Health, Inc. Moreover, depletion of GP73 in NRCMs relieved LPS-induced cardiomyocyte apoptosis and activated myocardial autophagy. Therefore, GP73 is a negative regulator in LPS-induced cardiac dysfunction by promoting cardiomyocyte apoptosis and inhibiting cardiomyocyte autophagy. All rights reserved.

Article 40

Article 40

Journal of Cardiovascular Pharmacology

OCTOBER 26, 2023

Copyright © 2023 Wolters Kluwer Health, Inc. Based on a review of the mechanisms that regulate ferroptosis, this paper explores the most recent research on the role of ferroptosis in the major pathological changes associated with CVDs, in order to provide new perspectives and strategies for cardiovascular research and clinical treatment.

Cardiovascular Disease 40

Cardiovascular Disease Research Article 40

Journal of Cardiovascular Pharmacology

DECEMBER 14, 2023

Copyright © 2023 Wolters Kluwer Health, Inc. These results suggest that Kir channels play a more important role than KATP channels in regulating vascular tone in larger arteries and that the activity of the Kir channel is enhanced by the PKC pathway. All rights reserved.

Aortic 52

Aortic Heart Failure Cardiovascular Disease Article 52